As we age, our brain undergoes a number of changes at the cellular and molecular levels. These changes, such as those associated with protein removal through autophagy, lead to the aggregation of misfolded proteins and eventually to the disruption of the nuclear membrane. Age-related disruption of these cellular events is strongly associated with diseases, such as Alzheimer's disease (AD), the most common form of dementia. Much of the brain malfunction during AD is related with the beta-amyloid peptide that is generated because of incorrect cleavage of the amyloid precursor protein (APP). This incorrect cleavage of APP has been associated with dysfunction of the presenilin-1 (PS-1) protein. Alterations in the PS-1 gene have been associated with nuclear membrane disruption and autophagy impairment. A screen of mRNA transcripts in our laboratory identified a splicing variant of PS-1 (PS-1 (SV)) that is highly expressed in AD brain samples. The role of PS-1(SV) during AD and aging is unknown. Since current AD pharmacological therapies are not effective, there is critical need to find treatment strategies. One promising alternative is caloric restriction (CR), the reduction in dietary caloric intake without inducing malnutrition, which has been shown to increase autophagy, reduce risk of AD and extend lifespan in various species. A new class of compounds called CR mimetics (CRms), which mimic the effects of CR without the need for dietary intervention, have been identified. The C. elegans model is widely used to study aging and neurodegeneration. The
sel-12(
or131) strain, which carries a loss-of-function
sel-12, the worm homologue of PS-1, exhibits an egg-laying defect (which is often associated with aging), a reduction in lifespan and a loss of nuclear membrane integrity. Our preliminary results, based on transient expression of PS-1 in the
sel-12(
or131) background, confirms that PS-1(WT) can rescue the egg-laying defect, but that PS-1(SV) cannot, suggesting that the PS-1(SV) is non-functional, which might underlie its influence on age-related phenotypes. Because the defects displayed by the
sel-12 strain can be, in part, attributed to the damaged autophagy, it represents an ideal model to test if the CRms, metformin, resveratrol and everolimus, which have already shown to rescue experimental autophagy impairment, can alleviate age-related phenotypes found in C. elegans PS-1(SV)::
sel-12.